Fimasartan in the Senior Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

July 15, 2016

Primary Completion Date

August 19, 2019

Study Completion Date

December 9, 2019

Conditions
The Elderly (≥ 70 Years) With Essential Hypertension
Interventions
DRUG

Fimasartan or Fimasartan/Hydrochlorothiazide

The treatment in this clinical study starts with fimasartan 30 mg; if blood pressure is not controlled (siSBP ≥ 140 mmHg or siDBP ≥ 90 mmHg), the dose is escalated once gradually, and then a diuretic combination is administered. The escalation of dose and administration of diuretic combination are decided after checking blood pressure 4 weeks after the administration of each investigational product.

DRUG

Perindopril or Perindopril/Indapamide

The treatment in this clinical study starts with penrindopril 2.5 mg; if blood pressure is not controlled (siSBP ≥ 140 mmHg or siDBP ≥ 90 mmHg), the dose is escalated once gradually, and then a diuretic combination is administered. The escalation of dose and administration of diuretic combination are decided after checking blood pressure 4 weeks after the administration of each investigational product.

Trial Locations (1)

Unknown

Seoul National University Bundang, Seoul

All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY